Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells - Sorbonne Université
Article Dans Une Revue Nucleic Acid Therapeutics Année : 2020

Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells

Dates et versions

hal-02905771 , version 1 (23-07-2020)

Identifiants

Citer

Nisha Verwey, Isabella Gazzoli, Sabine Krause, Kamel Mamchaoui, Vincent Mouly, et al.. Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells. Nucleic Acid Therapeutics, 2020, 30 (2), pp.71-79. ⟨10.1089/nat.2019.0788⟩. ⟨hal-02905771⟩
51 Consultations
0 Téléchargements

Altmetric

Partager

More